FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108969834> ?p ?o ?g. }

• W2108969834 endingPage "385" @default.
• W2108969834 startingPage "378" @default.
• W2108969834 abstract "Background Daunorubicin is an anthracycline anti-tumor agent; anthracycline chemotherapy in cancer can cause severe cardiomyopathy leading to a frequently fatal congestive heart failure; the first-line treatment is diuretics and digoxin. Recently, angiotensin-converting enzyme inhibitors have been shown to be effective in the treatment of such toxicity. The purpose of this study was to investigate the effects of angiotensin II type-1 receptor antagonist (candesartan) in a rat model of daunorubicin-induced cardiomyopathy. Methods Rats were treated with a cumulative dose of 9 mg/kg body weight daunorubicin (i.v.). 28 days later, after the development of cardiomyopathy, animals were randomly assigned to candesartan-treated (5 mg/kg/day, p.o.) or vehicle-treated groups; age-matched normal rats were used as the control group. Candesartan treatment was continued for 28 days. Hemodynamic and echocardiographic parameters were measured, cardiac protein and mRNA were analyzed, and histopathological analyses of myocardial fibrosis, cell size and apoptosis were conducted. Results Following cardiomyopathy, left ventricular end diastolic pressure and left ventricular systolic dimension were significantly elevated; while % fractional shortening and Doppler E/A ratio were significantly reduced. Cardiomyopathic hearts showed significant increases in % fibrosis, % apoptosis, and myocyte diameter/body weight ratio; candesartan treatment reversed these changes. Fas-L protein overexpression in myopathic hearts was significantly suppressed by treatment with candesartan. Moreover, SERCA2 mRNA and protein expression were both down-regulated in myopathic hearts and restored to normal by candesartan treatment, significantly. Conclusions Our findings suggest that candesartan treatment significantly improved the left ventricular function and reversed the myocardial pathological changes investigated in this model of daunorubicin-induced cardiomyopathy; suggesting its potentials in limiting daunorubicin cardiotoxicity." @default.
• W2108969834 created "2016-06-24" @default.
• W2108969834 creator A5002455860 @default.
• W2108969834 creator A5023350614 @default.
• W2108969834 creator A5034899583 @default.
• W2108969834 creator A5035088386 @default.
• W2108969834 creator A5038457825 @default.
• W2108969834 creator A5055227838 @default.
• W2108969834 creator A5056397749 @default.
• W2108969834 creator A5068445895 @default.
• W2108969834 creator A5082229850 @default.
• W2108969834 creator A5090085436 @default.
• W2108969834 creator A5090944100 @default.
• W2108969834 creator A5006836885 @default.
• W2108969834 date "2006-06-01" @default.
• W2108969834 modified "2023-10-17" @default.
• W2108969834 title "Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats" @default.
• W2108969834 cites W1967139008 @default.
• W2108969834 cites W1967995621 @default.
• W2108969834 cites W1969182421 @default.
• W2108969834 cites W1973431405 @default.
• W2108969834 cites W1977029462 @default.
• W2108969834 cites W1979108017 @default.
• W2108969834 cites W1991510772 @default.
• W2108969834 cites W1996063013 @default.
• W2108969834 cites W1996423501 @default.
• W2108969834 cites W1997608889 @default.
• W2108969834 cites W1998838410 @default.
• W2108969834 cites W2013330212 @default.
• W2108969834 cites W2013913095 @default.
• W2108969834 cites W2015043543 @default.
• W2108969834 cites W2022794649 @default.
• W2108969834 cites W2023470676 @default.
• W2108969834 cites W2028111124 @default.
• W2108969834 cites W2030264882 @default.
• W2108969834 cites W2030843830 @default.
• W2108969834 cites W2031569549 @default.
• W2108969834 cites W2049443309 @default.
• W2108969834 cites W2051550496 @default.
• W2108969834 cites W2053581424 @default.
• W2108969834 cites W2056359548 @default.
• W2108969834 cites W2057045161 @default.
• W2108969834 cites W2071224863 @default.
• W2108969834 cites W2090243629 @default.
• W2108969834 cites W2095241287 @default.
• W2108969834 cites W2119492932 @default.
• W2108969834 cites W2134579594 @default.
• W2108969834 cites W2136024858 @default.
• W2108969834 cites W2163331945 @default.
• W2108969834 cites W2170143689 @default.
• W2108969834 cites W2173231961 @default.
• W2108969834 doi "https://doi.org/10.1016/j.ijcard.2005.08.061" @default.
• W2108969834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16324756" @default.
• W2108969834 hasPublicationYear "2006" @default.
• W2108969834 type Work @default.
• W2108969834 sameAs 2108969834 @default.
• W2108969834 citedByCount "56" @default.
• W2108969834 countsByYear W21089698342012 @default.
• W2108969834 countsByYear W21089698342013 @default.
• W2108969834 countsByYear W21089698342014 @default.
• W2108969834 countsByYear W21089698342015 @default.
• W2108969834 countsByYear W21089698342016 @default.
• W2108969834 countsByYear W21089698342017 @default.
• W2108969834 countsByYear W21089698342018 @default.
• W2108969834 countsByYear W21089698342019 @default.
• W2108969834 countsByYear W21089698342020 @default.
• W2108969834 countsByYear W21089698342022 @default.
• W2108969834 countsByYear W21089698342023 @default.
• W2108969834 crossrefType "journal-article" @default.
• W2108969834 hasAuthorship W2108969834A5002455860 @default.
• W2108969834 hasAuthorship W2108969834A5006836885 @default.
• W2108969834 hasAuthorship W2108969834A5023350614 @default.
• W2108969834 hasAuthorship W2108969834A5034899583 @default.
• W2108969834 hasAuthorship W2108969834A5035088386 @default.
• W2108969834 hasAuthorship W2108969834A5038457825 @default.
• W2108969834 hasAuthorship W2108969834A5055227838 @default.
• W2108969834 hasAuthorship W2108969834A5056397749 @default.
• W2108969834 hasAuthorship W2108969834A5068445895 @default.
• W2108969834 hasAuthorship W2108969834A5082229850 @default.
• W2108969834 hasAuthorship W2108969834A5090085436 @default.
• W2108969834 hasAuthorship W2108969834A5090944100 @default.
• W2108969834 hasConcept C104849204 @default.
• W2108969834 hasConcept C126322002 @default.
• W2108969834 hasConcept C134018914 @default.
• W2108969834 hasConcept C164705383 @default.
• W2108969834 hasConcept C2776694085 @default.
• W2108969834 hasConcept C2778198053 @default.
• W2108969834 hasConcept C2778797674 @default.
• W2108969834 hasConcept C2780036600 @default.
• W2108969834 hasConcept C2781021840 @default.
• W2108969834 hasConcept C2908929049 @default.
• W2108969834 hasConcept C71924100 @default.
• W2108969834 hasConcept C78085059 @default.
• W2108969834 hasConcept C84393581 @default.
• W2108969834 hasConceptScore W2108969834C104849204 @default.
• W2108969834 hasConceptScore W2108969834C126322002 @default.
• W2108969834 hasConceptScore W2108969834C134018914 @default.
• W2108969834 hasConceptScore W2108969834C164705383 @default.

• next